A Study of Choydar Flow-Directed Mesh Stent in the Treatment of Unruptured Intracranial Aneurysms

NCT ID: NCT07228312

Last Updated: 2026-01-16

Basic Information

• Recruitment Status: NOT_YET_RECRUITING
• Total Enrollment: 200 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2025-12-25
• Study Completion Date: 2028-10-31

Brief Summary

The purpose of this study is to assess how safe choydar flow-directed mesh stent is and how well it works in the treatment of unruptured intracranial aneurysms (a condition in which a bulging blood vessel in the brain can burst and cause bleeding) in a real-world setting.

Conditions

Intracranial Aneurysm

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Choydar Flow-Directed Mesh Stent

The choydar flow-directed mesh stent will be used in accordance to its Instructions For Use (IFU) in participants with unruptured intracranial aneurysms. Participants will not receive any other intervention as a part of this study.

No interventions assigned to this group

Eligibility Criteria

Inclusion Criteria

• Presence of unruptured aneurysms in the internal carotid artery (from the petrous segment to the distal end) or vertebral artery identified by digital subtraction angiography (DSA), computed tomography angiography (CTA), or magnetic resonance angiography (MRA) prior to surgery. The aneurysm must have a neck width greater than or equal to (>=) 4 millimeters (mm) or a dome-to-neck ratio less than (<) 2, and the parent artery diameter must be >= 2.0 mm and less than or equal to (<=) 6.0 mm, including saccular and fusiform aneurysms
• Participants and/or their authorized representatives understand the purpose of the study, and are willing to voluntarily participate in the study and sign the informed consent form (ICF)
• Prior to enrollment, a clinical decision has already been made to use the choydar flow-directed mesh stent
• Participants who are willing and able to return for all follow-up visits as required by the study protocol

• Presence of unruptured aneurysms in the internal carotid artery (from the petrous segment to the distal end) or vertebral artery identified by DSA during the procedure. The aneurysm must have a neck width >= 4 mm or a dome-to-neck ratio < 2, and the parent artery diameter must be >= 2.0 mm and <= 6.0 mm, including saccular and fusiform aneurysms

Exclusion Criteria

• Participants with anatomy are unsuitable for flow diverter passage or placement or lesions unsuitable for flow diverter delivery and deployment (for example, the lesion vessel is excessively tortuous or tiny, the flow diverter cannot reach the lesion site, stenosis exists in the target vessel of recurrent aneurysm, or the flow diverter is not completely deployed)
• Participants who are allergic to contrast media
• Participants who are allergic to nickel-titanium alloy or platinum-tungsten alloy
• Participants who are contraindicated for antiplatelet and/or anticoagulant therapy
• Participants with active bacterial infections
• Participants who are confirmed positive pregnancy (for example, via test or oral communication) according to the site-specific standard of care
• Participants who are currently participating in an investigational (drug, device, etc.) clinical study that may confound the study endpoints (excluding observational, natural history, and/or epidemiological studies that do not require interventions)

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Johnson & Johnson Medical (Shanghai) Ltd.

INDUSTRY

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Johnson & Johnson Medical (Shanghai) Ltd. Clinical Trial

Role: STUDY_DIRECTOR

Johnson & Johnson Medical (Shanghai) Ltd.

Central Contacts

Study Contact

Role: CONTACT

Participate-In-This-Study1@its.jnj.com

Other Identifiers

CNV202507

Identifier Type: -

Identifier Source: org_study_id